Albert Beraldo
Direktor/Vorstandsmitglied bei MEDICENNA THERAPEUTICS CORP.
Vermögen: 455 000 $ am 30.04.2024
Aktive Positionen von Albert Beraldo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDICENNA THERAPEUTICS CORP. | Direktor/Vorstandsmitglied | 22.11.2016 | - |
Independent Dir/Board Member | 22.11.2016 | - | |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Direktor/Vorstandsmitglied | - | - |
Idoman Ltd. | Präsident | 01.07.2008 | - |
Global Transplant Solutions, Inc.
Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Global Transplant Solutions, Inc. provides solutions for the preservation of human organs. | Vorsitzender | - | - |
Karriereverlauf von Albert Beraldo
Ehemalige bekannte Positionen von Albert Beraldo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PURE GLOBAL CANNABIS INC. | Direktor/Vorstandsmitglied | 01.07.2018 | 01.05.2020 |
Independent Dir/Board Member | 01.07.2018 | 01.05.2020 | |
HELIX BIOPHARMA CORP. | Direktor/Vorstandsmitglied | 28.01.2016 | 14.07.2017 |
Alveda Pharmaceuticals, Inc.
Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Alveda Pharmaceuticals, Inc. sells and distributes pharmaceuticals and medical devices. Its products are available in different sizes and formats including glass vials, ampoules, syringes, and polyampoules. The firm''s consulting services cover areas, such as, product development, warehousing and logistics, manufacturing, quality control testing and product analysis, and labeling and package development. It serves hospitals, buying groups, wholesalers, individual physicians, pharmacists, and patients. The company was founded in November 2006 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 01.11.2006 | 01.11.2015 |
Vorstandsvorsitzender | 01.11.2006 | 01.11.2015 | |
Gründer | 01.11.2006 | 01.11.2015 | |
Präsident | 01.11.2006 | 01.11.2015 | |
TELESTA THERAPEUTICS INC | Direktor/Vorstandsmitglied | 21.09.2011 | 01.02.2014 |
Independent Dir/Board Member | 21.09.2011 | 01.02.2014 | |
Bioniche Pharma Group Ltd.
Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Bioniche Pharma Group Ltd. is a specialty pharmaceutical company involved primarily in the development, manufacturing, and marketing of sterile injectable products. The company sells a number of non-branded products in the U.S. market for which it has received approved Abbreviated New Drug Applications. It also sells its branded product Suplasyn in 30 countries globally. The firm's products are sold to both the primary care and hospital markets in the U.S., Canada, and Europe. The company was founded in 2000 and is headquartered in Casla, Ireland. | Präsident | - | 01.01.2006 |
░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Albert Beraldo
University of Windsor | Undergraduate Degree |
Statistik
International
Kanada | 10 |
Vereinigtes Königreich | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 6 |
President | 4 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
HELIX BIOPHARMA CORP. | Health Technology |
MEDICENNA THERAPEUTICS CORP. | Health Technology |
PURE GLOBAL CANNABIS INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Telesta Therapeutics, Inc.
Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
Bioniche Pharma Group Ltd.
Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Bioniche Pharma Group Ltd. is a specialty pharmaceutical company involved primarily in the development, manufacturing, and marketing of sterile injectable products. The company sells a number of non-branded products in the U.S. market for which it has received approved Abbreviated New Drug Applications. It also sells its branded product Suplasyn in 30 countries globally. The firm's products are sold to both the primary care and hospital markets in the U.S., Canada, and Europe. The company was founded in 2000 and is headquartered in Casla, Ireland. | Health Technology |
Alveda Pharmaceuticals, Inc.
Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Alveda Pharmaceuticals, Inc. sells and distributes pharmaceuticals and medical devices. Its products are available in different sizes and formats including glass vials, ampoules, syringes, and polyampoules. The firm''s consulting services cover areas, such as, product development, warehousing and logistics, manufacturing, quality control testing and product analysis, and labeling and package development. It serves hospitals, buying groups, wholesalers, individual physicians, pharmacists, and patients. The company was founded in November 2006 and is headquartered in Toronto, Canada. | Retail Trade |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Health Technology |
Idoman Ltd. | |
Vetrepharm Canada, Inc. | |
Global Transplant Solutions, Inc.
Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Global Transplant Solutions, Inc. provides solutions for the preservation of human organs. | Health Services |
- Börse
- Insiders
- Albert Beraldo
- Erfahrung